SEC Form D · filed January 21, 2021
EYEGATE PHARMACEUTICALS INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Bernard Malfroy-Camine · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorSteven Boyd · Waltham, MADirectorPraveen Tyle · Waltham, MADirectorPaul Chaney · Waltham, MADirectorKeith Maher · Waltham, MADirectorMorton Goldberg · Waltham, MADirectorThomas Hancock · Waltham, MADirectorSarah Romano · Waltham, MAExecRodney D. Brown · LEESBURG, VAExec · DirectorJustin Jory · Woodbridge, VADirectorTom Bruderman · Redmond, WADirectorDaniel Wachtler · Redmond, WADirectorDavid Wurtzbacher · Woodbridge, VAExecScott Fletcher · Ross, CADirectorJay Lee · Redmond, WADirectorTony Wood · Vancouver, British Columbia, CanadaDirectorRandy H. Hopkins · Meridian, IDDirectorBrian Mcveigh · Hatfield, PADirectorJohn Iadeluca · New York, NYDirectorAccumulus Capital Partners, LLC · New York, NYDirectorSoutheast Asset Advisors, LLC · Thomasville, GADirectorAmir Nashat · CAMBRIDGE, MADirectorPaula Ragan · CAMBRIDGE, MADirectorRichard Young · CAMBRIDGE, MAExecJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorJoshua G. Kazam · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗